$961 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 148 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | GlaxoSmithKline PLCcall | $0 | – | -291,300 | -100.0% | -0.00% | – | |
| NVAX | Exit | Novavax Inc | $0 | – | -1,543 | -100.0% | -0.00% | – |
| Exit | Energy Select Sector SPDR Fundput | $0 | – | -50,000 | -100.0% | -0.02% | – | |
| ICL | Exit | Israel Chemicals Ltd | $0 | – | -40,116 | -100.0% | -0.05% | – |
| MLNX | Exit | Mellanox Technologies Ltd | $0 | – | -12,517 | -100.0% | -0.09% | – |
| KBIO | Exit | KaloBios Pharmaceuticals Inc | $0 | – | -349,560 | -100.0% | -0.10% | – |
| Exit | Ardelyx Inc | $0 | – | -32,700 | -100.0% | -0.10% | – | |
| ACRX | Exit | AcelRx Pharmaceuticals Inc | $0 | – | -100,000 | -100.0% | -0.12% | – |
| ONTY | Exit | Oncothyreon Inc | $0 | – | -428,000 | -100.0% | -0.14% | – |
| ZSPH | Exit | ZS Pharma Inc | $0 | – | -20,682 | -100.0% | -0.15% | – |
| RPRX | Exit | Repros Therapeutics Inc | $0 | – | -100,000 | -100.0% | -0.17% | – |
| RXDX | Exit | Ignyta Inc | $0 | – | -179,055 | -100.0% | -0.21% | – |
| WIX | Exit | Wix.com Ltd | $0 | – | -59,108 | -100.0% | -0.21% | – |
| Exit | Amgen Inc | $0 | – | -8,550 | -100.0% | -0.23% | – | |
| Exit | Valeant Pharmaceuticals Interncall | $0 | – | -97,200 | -100.0% | -0.24% | – | |
| CKP | Exit | Check Point Software Technolog | $0 | – | -19,688 | -100.0% | -0.26% | – |
| CTIC | Exit | Cell Therapeutics Inc | $0 | – | -750,000 | -100.0% | -0.30% | – |
| LJPC | Exit | La Jolla Pharmaceutical Co | $0 | – | -100,230 | -100.0% | -0.32% | – |
| NICE | Exit | NICE Systems Ltdsponsored adr | $0 | – | -39,652 | -100.0% | -0.34% | – |
| ENTA | Exit | Enanta Pharmaceuticals Inc | $0 | – | -40,000 | -100.0% | -0.35% | – |
| VTL | Exit | Vital Therapies Inc | $0 | – | -81,900 | -100.0% | -0.35% | – |
| CSX | Exit | CSX Corp | $0 | – | -59,648 | -100.0% | -0.37% | – |
| ZFGN | Exit | Zafgen Inc | $0 | – | -72,100 | -100.0% | -0.38% | – |
| CEMP | Exit | Cempra Inc | $0 | – | -100,000 | -100.0% | -0.40% | – |
| BCOMF | Exit | B Communications Ltd | $0 | – | -134,174 | -100.0% | -0.41% | – |
| SRPT | Exit | Sarepta Therapeutics Inc | $0 | – | -175,000 | -100.0% | -0.43% | – |
| PRQR | Exit | ProQR Therapeutics BV | $0 | – | -130,000 | -100.0% | -0.48% | – |
| P103PS | Exit | NPS Pharmaceuticals Inc | $0 | – | -80,000 | -100.0% | -0.49% | – |
| ESRX | Exit | Express Scripts Holding Co | $0 | – | -33,966 | -100.0% | -0.49% | – |
| DRNA | Exit | Dicerna Pharmaceuticals Inc | $0 | – | -176,802 | -100.0% | -0.50% | – |
| Exit | Alder Biopharmaceuticals Inc | $0 | – | -100,000 | -100.0% | -0.50% | – | |
| CLDN | Exit | Celladon Corp | $0 | – | -150,656 | -100.0% | -0.50% | – |
| Exit | Arrowhead Research Corp | $0 | – | -400,000 | -100.0% | -0.50% | – | |
| ACOR | Exit | Acorda Therapeutics Inc | $0 | – | -79,105 | -100.0% | -0.55% | – |
| VRTX | Exit | Vertex Pharmaceuticals Inc | $0 | – | -30,000 | -100.0% | -0.61% | – |
| ITRN | Exit | Ituran Location and Control Lt | $0 | – | -168,203 | -100.0% | -0.63% | – |
| CYTK | Exit | Cytokinetics Inc | $0 | – | -493,212 | -100.0% | -0.67% | – |
| Exit | Gilead Sciences Inccall | $0 | – | -394,200 | -100.0% | -0.67% | – | |
| GSK | Exit | GlaxoSmithKline PLCsponsored adr | $0 | – | -98,200 | -100.0% | -0.72% | – |
| XLF | Exit | Financial Select Sector SPDR Fsbi int-finl | $0 | – | -210,000 | -100.0% | -0.88% | – |
| Exit | Amgen Inccall | $0 | – | -120,200 | -100.0% | -0.93% | – | |
| MYL | Exit | Mylan Inc/PA | $0 | – | -97,100 | -100.0% | -0.93% | – |
| Exit | Apple Inc | $0 | – | -52,803 | -100.0% | -0.99% | – | |
| PCYC | Exit | Pharmacyclics Inc | $0 | – | -48,840 | -100.0% | -1.02% | – |
| LLY | Exit | Eli Lilly & Co | $0 | – | -87,100 | -100.0% | -1.02% | – |
| Exit | AstraZeneca PLCsponsored adr | $0 | – | -86,637 | -100.0% | -1.04% | – | |
| GCVRZ | Exit | Sanofiright 12/31/2020 | $0 | – | -67,960 | -100.0% | -1.06% | – |
| Exit | Bellicum Pharmaceuticals | $0 | – | -331,514 | -100.0% | -1.18% | – | |
| Exit | Allergan Inc/United Statescall | $0 | – | -250,000 | -100.0% | -1.40% | – | |
| ESLT | Exit | Elbit Systems Ltdord | $0 | – | -144,759 | -100.0% | -1.51% | – |
| MNKKQ | Exit | Mallinckrodt PLC | $0 | – | -90,940 | -100.0% | -1.53% | – |
| Exit | Merck & Co Inc | $0 | – | -167,530 | -100.0% | -1.62% | – | |
| ISRL | Exit | Isramco Negev 2 LP | $0 | – | -64,958,387 | -100.0% | -1.90% | – |
| SLXP | Exit | SALIX PHARMACEUTICALS LT | $0 | – | -158,500 | -100.0% | -3.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.